Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

4.940 -0.210 (-4.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,784,621
Open 5.120
Bid (Size) 4.950 (1)
Ask (Size) 4.990 (2)
Prev. Close 5.150
Today's Range 4.705 - 5.240
52wk Range 1.050 - 5.508
Shares Outstanding 64,465,037
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session
 
Via Benzinga
Why Is Taysha Gene Therapies Stock Falling Friday?
Taysha Gene Therapies shares fall after regaining full rights to Rett syndrome drug TSHA-102 and finalizing FDA alignment for pivotal trial. 
Via Benzinga

Performance

YTD
+167.0%
+167.0%
1 Month
+72.1%
+72.1%
3 Month
+83.6%
+83.6%
6 Month
+171.4%
+171.4%
1 Year
+148.2%
+148.2%

More News

Read More
Taysha Gene Therapies Stock Soars To 3-Year High After FDA Boost — Wall Street Calls Rett Drug ‘Derisked’ And Ahead Of Rivals
Via Stocktwits
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
What's Next: Taysha Gene Therapies's Earnings Preview
Via Benzinga
Demystifying Taysha Gene Therapies: Insights From 6 Analyst Reviews
Via Benzinga
Discover the most active stocks in Thursday's session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Here are the top movers in Thursday's session.
Via Chartmill
Where Taysha Gene Therapies Stands With Analysts
Via Benzinga
Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy
Via Stocktwits
Which stocks are gapping on Thursday?
Via Chartmill
Top 2 Health Care Stocks That May Keep You Up At Night This Month
Via Benzinga
What's Driving the Market Sentiment Around Taysha Gene Therapies?
Via Benzinga
Is Taysha Gene Therapies Gaining or Losing Market Support?
Via Benzinga
A Glimpse Into The Expert Outlook On Taysha Gene Therapies Through 11 Analysts
Via Benzinga
Beyond The Numbers: 10 Analysts Discuss Taysha Gene Therapies Stock
Via Benzinga
Retail Buzz Surges Around Taysha Gene Therapies After Positive Rett Syndrome Trial Data
Via Stocktwits
Earnings Scheduled For August 12, 2025
Via Benzinga
Why Is Taysha Gene Therapies Stock Trading Higher On Thursday?
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
Via Chartmill
Expert Outlook: Taysha Gene Therapies Through The Eyes Of 6 Analysts
Via Benzinga

Frequently Asked Questions

Is Taysha Gene Therapies, Inc. - Common Stock publicly traded?
Yes, Taysha Gene Therapies, Inc. - Common Stock is publicly traded.
What exchange does Taysha Gene Therapies, Inc. - Common Stock trade on?
Taysha Gene Therapies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Taysha Gene Therapies, Inc. - Common Stock?
The ticker symbol for Taysha Gene Therapies, Inc. - Common Stock is TSHA on the Nasdaq Stock Market
What is the current price of Taysha Gene Therapies, Inc. - Common Stock?
The current price of Taysha Gene Therapies, Inc. - Common Stock is 4.940
When was Taysha Gene Therapies, Inc. - Common Stock last traded?
The last trade of Taysha Gene Therapies, Inc. - Common Stock was at 10/22/25 04:00 PM ET
What is the market capitalization of Taysha Gene Therapies, Inc. - Common Stock?
The market capitalization of Taysha Gene Therapies, Inc. - Common Stock is 318.46M
How many shares of Taysha Gene Therapies, Inc. - Common Stock are outstanding?
Taysha Gene Therapies, Inc. - Common Stock has 318M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.